Durmuş BURGUCU

Effect of short-term in vitro antibiotic administration into the human umbilical cord tissue on cfu count and mesenchymal stem cell immunophenotype

Mesenchymal stem cells play important roles in regenerative and reparative medicine applications. Their differentiation and proliferation abilities both in the human body and in the laboratory, environment have been revealed through many clinical and pre-clinical trials. Umbilical cord tissue is an important source of mesenchymal stem cells and has become a popular option in cord blood banking, especially in the last decade. As done for the cord blood, the steps of obtaining, transferring, processing, and cryopreserving umbilical cord tissue are defined by standard procedures. However, there is limited information about the microbiological contamination rate of tissues and their decontamination before the procedure. This study aimed to assess the effect of in vitro short-term antibiotic treatment applied to the umbilical cord tissue obtained via superficial ethanol disinfection immediately after birth on the formation of colony-forming units (CFUs) and immunophenotype of the mesenchymal stem cells. For this purpose, tissues obtained from 10 individuals were evaluated in three different groups that included the control group and groups of tissues with 5- and 10-min antibiotic treatment. There was no significant difference among the groups in the expression levels of CD45, CD34, CD73, CD105, and CD44, which are the markers used in immunophenotyping. Similarly, no difference was found in CFU formation either. The present study has revealed for the first time that an antibiotic preparation used in in vitro cell culture for cord tissue banking can be used safely in tissue preparation and banking stages. Our results show that short-term in vitro antibiotic administration can contribute to the standard formation during decontamination/disinfection stages in cord tissue banking.

PDF

___

1. Gluckman E, Broxmeyer HA, Auerbach AD, et al. Hematopoietic reconstitution in a patient with Fanconi's anemia by means of umbilicalcord blood from an HLA-identical sibling. N Engl J Med. 1989;321:1174-8.

2. Ballen KK, Gluckman E, Broxmeyer HE. Umbilical cord blood transplantation: the first 25 years and beyond. Blood. 2013;122:491-8.

3. Mayani H, Wagner JE, Broxmeyer HE. Cord blood research, banking, and transplantation: achievements, challenges, and perspectives. Bone Marrow Transplant. 2020;55:48-61.

4. Zhu L, Lv H, Wang Y, et al. Microbial screening of unrelated cord blood units in a Chinese cord blood bank. Transfus Med. 2013;23:438-41.

5. Chen SH, Zheng YJ, Yang SH, et al. Microbial contamination of the Tzu- Chi Cord Blood Bank from 2005 to 2006. Acta Paediatr Taiwan. 2008;49:9- 13.

6. Couto PS, Shatirishvili G, Bersenev A, et al. First decade of clinical trials and published studies with mesenchymal stromal cells from umbilical cord tissue. Regen Med. 2019;14:309-19.

7. Dulugiac M, Moldovan L, Zarnescu O. Comparative studies of mesenchymal stem cells derived from different cord tissue compartments - The influence of cryopreservation and growth media. Placenta. 2015;36:1192-203.

8. Dominici M, Le Blanc K, Mueller I, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006;8:315-7.

9. Gao F, Chiu SM, Motan DA, et al. Mesenchymal stem cells and immunomodulation: current status and future prospects. Cell Death Dis. 2016;7(1): e2062. Published 2016 Jan 21.

10. Gong W, Han Z, Zhao H, et al. Banking human umbilical cord-derived mesenchymal stromal cells for clinical use. Cell Transplant. 2012;21:207- 16.

11. Ganesh Kumar Sarvesa, Chirayu Padhiar, Ashika Asha. Comparison study of 70% ethanol effect on direct and retrival culture of contaminated umbilical cord tissue for expansion of msc at lifecell. Cytotherapy volume 17, issue 6, supplement, s36, June 01, 2015